Bryan Howcroft

MediPharm Labs Corp. (OTC: MEDIF) a pharmaceutical company specializing in precision-based cannabinoids, announced on Thursday its financial results for the Fourth Quarter and Full-Year that ended on December 31, 2021. 2021 Highlights  International sales more than doubled in 2021, to $9.5...

MediPharm Labs Corp. (OTCQX: MEDIF) (TSXV:LABS) (FSE:MLZ) has acquired the intellectual property portfolio of Shelter Cannabis, including cannabis dried flower and pre-roll products, manufacturing know-how, trademarks, marketing assets and provincial listings. MediPharm will pay Shelter based on an...

CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) has completed a Drug Master File (DMF) process for CBD Active Pharmaceutical Ingredient (API) for the US Federal Drug Administration (FDA). Why It Matters? The DMF will enable MediPharm to supply approved...

CBD-focused pharmaceutical company MediPharm Labs Corp. (TSXV:) (OTCQX: MEDIF) (FSE:MLZ) revealed Wednesday it has finalized all payments required under its 2020 $41 million unsecured convertible debt. “MediPharm continues on its plan and path to profitability, and paying off our convertible...

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced Thursday it has appointed Bryan Howcroft as chief executive officer and director, effective November 15, 2021. Howcroft has more than two decades of leadership experience covering various industries, such as medical devices,...